智通财经网·2025-12-16 07:16Group 1 - The stock of Zhaoyan New Drug (06127) has fallen over 5%, but it has still seen a cumulative increase of more than 24% in the month [1] - As of the report, the stock price is at 20.5 HKD with a trading volume of 151 million HKD [1] - The price of experimental monkeys is on an upward trend, reaching approximately 140,000 RMB each as of December 9, 2025 [1] Group 2 - According to Founder Securities, the demand for experimental monkeys is increasing due to a steady recovery in preclinical CRO orders, while supply-side expansion is challenging in the short term [1] - Some monkey farms have reported that their production capacity is already booked until the first quarter of 2026, indicating a tight supply-demand situation that is expected to persist [1] - For Zhaoyan New Drug, assuming an average price of 84,900 RMB per monkey in 2024 and an increase to 140,000 RMB by Q4 2025, the estimated new fair value in 2025 could be around 220 million RMB based on known quantities [1]